NLRP3 and atherosclerosis: Thus, the inhibition of caspase-1, NLRP3, or GSDMD in dyslipidemic and inflammatory contexts prevents endothelial pyroptosis and improves endothelial survival, thereby preserving vascular intima integrity, reducing vascular inflammation, and further attenuating the progression of atherosclerosis.